A Comparative Analysis of Radiobiological Models for Cell Surviving Fractions at High Doses

Abstract

For many years the linear-quadratic (LQ) model has been widely used to describe the effects of total dose and dose per fraction at low-to-intermediate doses in conventional fractionated radiotherapy. Recent advances in stereotactic radiosurgery (SRS) and stereotactic radiotherapy (SRT) have increased the interest in finding a reliable cell survival model, which will be accurate at high doses, as well. Different models have been proposed for improving descriptions of high dose survival responses, such as the Universal Survival Curve (USC), the Kavanagh-Newman (KN) and several generalizations of the LQ model, e.g. the Linear-Quadratic-Linear (LQL) model and the Padé Linear Quadratic (PLQ) model. The purpose of the present study is to compare a number of models in order to find the best option(s) which could successfully be used as a fractionation correction method in SRT. In this work, six independent experimental data sets were used: CHOAA8 (Chinese hamster fibroblast), H460 (non-small cell lung cancer, NSLC), NCI-H841 (small cell lung cancer, SCLC), CP3 and DU145 (human prostate carcinoma cell lines) and U1690 (SCLC). By detailed comparisons with these measurements, the performance of nine different radiobiological models was examined for the entire dose range, including high doses beyond the shoulder of the survival curves. Using the computed and measured cell surviving fractions, comparison of the goodness-of-fit for all the models was performed by means of the reduced χ²-test with a 95% confidence interval. The obtained results indicate that models with dose-independent final slopes and extrapolation numbers generally represent better choices for SRT. This is especially important at high doses where the final slope and extrapolation numbers are presently found to play a major role. The PLQ, USC and LQL models have the least number of shortcomings at all doses. The extrapolation numbers and final slopes of these models do not depend on dose. Their asymptotes for the cell surviving fractions are exponentials at low as well as high doses, and this is in agreement with the behaviour of the corresponding experimental data. This is an important improvement over the LQ model which predicts a Gaussian at high doses. Overall and for the highlighted reasons, it was concluded that the PLQ, USC and LQL models are theoretically well-founded. They could prove useful compared to the other proposed radiobiological models in clinical applications for obtaining uniformly accurate cell surviving fractions encountered in stereotactic high-dose radiotherapy as well as at medium and low doses.

Keywords

Biologically effective dose Hypofractionation Cell survival Radiobiological models

References

Garcia

L. M.

Leblanc

Wilkins

Raaphorst

G. P.

Fitting the linear-quadratic model to detailed data sets for different dose ranges. Phys Med Biol 51, 2813–2823 (2006). DOI: 10.1088/0031–9155/51/11/009.

Kirkpatrick

J. P.

Meyer

J. J.

Marks

L. B.

The Linear-Quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol 18, 240–243 (2008). DOI: 10.1016/j.semradonc.2008.04.005.

Guerrero

X. A.

Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys Med Biol 49, 4825–4835 (2004). DOI: 10.1088/0031–9155/49/20/012.

Park

Papiez

Zhang

Story

Timmerman

R. D.

Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 70, 847–852 (2008). DOI: 10.1016/j.ijrobp.2007.10.059.

Fowler

J. F.

Linear-quadratics is alive and well. Int J Radiat Oncol Biol Phys 72, 957 (2008). DOI: 10.1016/j.ijrobp.2008.06.1929.

Kavanagh

B. D.

Newman

Toward a universal survival curve. Int J Radiat Oncol Biol Phys 71, 958–959 (2008). DOI:10.1016/j.ijrobp.2008.03.016.

McKenna

Ahmad

Toward a universal survival curve. Int J Radiat Oncol Biol Phys 73, 640 (2009). DOI: 10.1016/j.ijrobp.2008.08.063.

Ekstrand

K. E.

The Hug-Kellerer equation as the universal survival curve. Phys Med Biol 55, N267–273 (2010). DOI: 10.1088/0031–9155/55/10/N01.

Hanin

L. G.

Zaider

Cell-survival probability at large doses: An alternative to the linear-quadratic model. Phys Med Biol 55, 4687–4702 (2010). DOI: 10.1088/0031–9155/55/16/005.

10.

Wang

J. Z.

Huang

S. S.

Yuh

W. T.

Mayr

N. A.

A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy. Sci Transl Med 2, 39–48 (2010). DOI: 10.1126/scitranslmed.3000864.

11.

Brahme

Accurate description of the cell survival and biological effect at low and high doses and LETs. J Rad Res (Tokyo) 52, 389–407 (2011). DOI: 10.1269/jrr.10129.

12.

Scholz

Kraft

Calculation of heavy ion inactivation probabilities based on track structure, X-ray sensitivity and target size. Radiat Prot Dosim 52, 29–33 (1994).

13.

Lind

B. K.

Persson

L. M.

Edgren

M. R.

Hedlof

Brahme

Repairable-conditionally repairable damage model based on dual poisson processes. Rad Res 160, 366–375 (2003). DOI: 10.1667/0033-7587(2003)160[0366:RRDMBO]2.0.CO;2.

14.

Bender

M. A.

Gooch

P. C.

The kinetics of X-ray survival of mammalian cells in vitro. Int J Radiat Biol 5, 133–145 (1962). DOI: 10.1080/09553006214550651.

15.

Carmichael

Degraff

W. G.

Camson

Radiation sensitivity of human lung cancer cell lines. Eur J Cancer Clin Oncol 25, 527–534 (1989). DOI: 10.1016/0277–5379(89)90266-6.

16.

Park

Papiez

Timmerman

R. D.

In reply to Drs. McKenna and Ahmad. Int J Radiat Oncol Biol Phys 73, 641 (2009). DOI: 10.1016/j.ijrobp.2008.10.001.

17.

Bergh

Nilsson

Ekman

Giovanella

Establishment and characterization of cell lines from human small and large cell carcinomas of the lung. Acta Pathol Microbiol Immunol Scand A 93, 133–147 (1985).

18.

Persson

L. M.

Lind

B. K.

Edgren

M. R.

Hedlöf

Brahme

RBE of 50 MV scanned bremsstrahlung beams determined using clonogenic assay. Int J Rad Biol 78, 275–284 (2002). DOI: 10.1080/0955300110101996.

19.

Puck

T. T.

Marcus

P. I.

Action of x-rays on mammalian cells. J Exp Med 103, 653–666 (1956). DOI: 10.1084/jem.103.5.653.

20.

Douglas

B. G.

Fowler

J. F.

The effect of multiple small doses of x-rays on skin reactions in the mouse and a basic interpretation. Rad Res 66, 401–426 (1976). DOI: 10.2307/3574407.

21.

Belkić

Dž.

Parametric analysis of time signals and spectra from perspectives of quantum physics and chemistry. Adv Quantum Chem 61, 145–260 (2011). DOI: 10.1016/B978–0–12–386013–2.00004-8.

22.

Belkić

Dž.

Belkić

Padé-Froissart exact signal-noise separation in nuclear magnetic resonance spectroscopy. J Phys B 44, 125003 (2011). DOI: 10.1088/0953–4075/44/12/125003.

23.

Belkić

Dž.

Belkić

High-resolution signal processing in magnetic resonance spectroscopy for early cancer diagnostics. Adv Quantum Chem 62, 245–347 (2011). DOI: 10.1016/B978–0–12–386477–2.00006-1.

24.

Lea

D. E.

Catcheside

The mechanism of the induction by radiation of chromosome aberrations in Tradescantia. J Genetics 44, 216–245 (1942).

25.

Sinclair

W. K.

The shape of radiation survival curves of mammalian cells cultured in vitro Biophysical aspects of radiation quality. IAEA, Vienna,

Technical Reports series no. 58. (1966).

26.

Hopewell

J. W.

Millar

W. T.

Ang

K. K.

Toward improving the therapeutic ratio in stereotactic radiosurgery: Selective modulation of the radiation responses of both normal tissues and tumor. J. Neurosurg 107, 84–93 (2007). DOI: 10.3171/JNS-07/07/0084.

27.

Zaider

There is no mechanistic basis for the use of the linear-quadratic expression in cellular survival analysis. Med Phys 25, 791–792 (1998). DOI: 10.1118/1.598430.

28.

Andisheh

Belkić

Dž.

Mavroidis

Alahverdi

Lind

B. K.

Toward improving the therapeutic ratio in stereotactic radiosurgery: Optimizing treatment protocols based on kinetics of repair of Sub-lethal radiation damage. Submitted to TCRT..